VentriPoint Diagnostics (CVE:VPT) Trading Down 14.7% – Here’s What Happened

by · The Markets Daily

VentriPoint Diagnostics Ltd. (CVE:VPTGet Free Report) shares fell 14.7% during mid-day trading on Wednesday . The stock traded as low as C$0.15 and last traded at C$0.15. 266,015 shares were traded during trading, a decline of 10% from the average session volume of 294,436 shares. The stock had previously closed at C$0.17.

VentriPoint Diagnostics Trading Down 9.1 %

The firm has a fifty day moving average price of C$0.11 and a 200-day moving average price of C$0.13. The company has a market capitalization of C$24.33 million, a price-to-earnings ratio of -4.63 and a beta of 0.39. The company has a debt-to-equity ratio of -58.56, a quick ratio of 6.67 and a current ratio of 0.28.

VentriPoint Diagnostics Company Profile

(Get Free Report)

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.

Further Reading